
Please try another search
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA (ixabepilone), a selective microtubule inhibitor in phase 2 for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company has a collaboration with Detsamma Investments Pty. Ltd. to develop Deflexifol for the treatment of solid tumors. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Daniel Douglas Von Hoff | 75 | - | Member of Scientific Advisory Board |
Ursula A. Matulonis | - | - | Member of Scientific Advisory Board |
Thomas H. Jensen | 45 | 2004 | Founder, Senior VP of Investor Relations & Director |
Joyce A. O'Shaughnessy | - | - | Member of Scientific Advisory Board |
James G. Cullem | 53 | 2021 | CEO, Chief Business Officer, SVP of Corporate Development, Secretary & Director |
Mansoor Raza Mirza | 62 | - | Member of Scientific Advisory Board |
Roberto Pili | - | 2022 | Member of Scientific Advisory Board |
Gerald W. McLaughlin | 55 | 2022 | Independent Chairman of the Board |
Joseph Walter Vazzano | 39 | 2023 | Independent Director |
Laura Benjamin | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review